Clinical Trials Logo

Acidosis, Lactic clinical trials

View clinical trials related to Acidosis, Lactic.

Filter by:

NCT ID: NCT00031161 Completed - Chronic Disease Clinical Trials

Prevention of Dichloroacetate Toxicity

Start date: September 2001
Phase: N/A
Study type: Interventional

This is a study to determine the safety of dichloroacetate (DCA) with a low-tyrosine diet given with or without nitisinone (NTBC) in children with chronic lactic acidosis (CLA).

NCT ID: NCT00015015 Completed - Lactic Acidosis Clinical Trials

Dichloroacetate Kinetics, Metabolism and Toxicology

Start date: December 1994
Phase: N/A
Study type: Observational

Dichloroacetate (DCA) is a product of water chlorination and a metabolite of certain industrial solvents, thus making it a chemical of environmental concern. However, DCA is also used as an investigational drug for treating various diseases of adults and children, at doses far greater than those to which humans are normally exposed in the environment. Our research involves how DCA is metabolized by healthy adults and by children with a fatal genetic disease, congenital lactic acidosis (CLA) who are treated with DCA.

NCT ID: NCT00004493 Completed - Lactic Acidosis Clinical Trials

Phase II Pilot Randomized Study of Sodium Dichloroacetate in Patients With Congenital Lactic Acidemia

Start date: September 1998
Phase: Phase 2
Study type: Interventional

OBJECTIVES: I. Determine the pharmacokinetics of sodium dichloroacetate (DCA) in patients with congenital lactic acidemia. II. Determine the efficacy of DCA in decreasing the frequency and/or severity of acute episodes of acidotic illness, improving linear growth, improving neurological or developmental function, or slowing neurological or developmental deterioration in these patients.

NCT ID: NCT00004490 Completed - Lactic Acidosis Clinical Trials

Phase III Randomized Study of Sodium Dichloroacetate in Children With Congenital Lactic Acidosis

Start date: October 1998
Phase: Phase 3
Study type: Interventional

OBJECTIVES: I. Compare the safety of sodium dichloroacetate (DCA) vs placebo in children with congenital lactic acidosis. II. Determine the quality of life of these patients. III. Determine the pharmacokinetics and metabolic fate of DCA over the course of drug administration in these patients.

NCT ID: NCT00004353 Completed - Lactic Acidosis Clinical Trials

Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia

Start date: December 1978
Phase: N/A
Study type: Observational

OBJECTIVES: I. Study the metabolism of pyruvate and related problems in patients with lactic acidemia. II. Define the nature of the metabolic defect.